Dr. Caroline M. Behler




Pacific Hematology Oncology Associates

California Pacific Medical Center

San Francisco, CA

Assistant Clinical Professor

Department of Medicine, University of California, San Francisco


Assistant Clinical Professor of Medicine

University of California, San Francisco

Department of Medicine

Division of Hematology and Oncology

Malignant Hematology and Bone Marrow Transplant

August 2007-April 2012

Chief, Malignant Hematology

San Francisco V.A. Medical Center

August 2007-April 2012


University of California, San Francisco

Hematology/Oncology Fellowship


University of California, San Francisco

Internal Medicine Residency


University of Washington School of Medicine

Doctor of Medicine with Honors, 2001

University of Washington School of Public Health

Master of Science, Pathobiology, 1999

University of Washington College of Arts and Sciences Honors Program Bachelor of Science, Cell and Molecular Biology, Cum Laude, With Distinction, 1994


Diplomate, American Board of Internal Medicine:Hematology, 2008

Diplomate, American Board of Internal Medicine: Oncology, 2007

Diplomate, American Board of Internal Medicine: Internal Medicine, 2004


Excellence in Teaching Award, Haile T. Debas Academy of Medical Educators.

University of California, San Francisco, 2010

Alpha Omega Alpha National Medical Honor Society, 2000

Hematology Award, American Federation for Medical Research, 1998

Phi Beta Kappa, University of Washington, 1993


American Society of Hematology, 2004-present


  Peer Reviewed Publications

1. Wieduwilt MK, Valles F, Behler CM, Hwang J, Issa S, McDermott M, Treseler P, O’Brien J, Shuman MA, Cha S, Damon LE and Rubenstein JL. Immunochemotherapy with Intensive Consolidation for Primary CNS

Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI, manuscript submitted.

2. Lu CM, Zhou L, Wang E, Feng S, Sebastian S, Behler C. Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation. Leuk Lymphoma. 2011; [Epub ahead of print]

3. Van Allen EM, Miyake T, Gunn N, Behler CM, Kohlwes J. Off-label use of rituximab in a multipayer insurance system. J Oncol Pract. 2011;7(2):76-9.

4. Behler CM, Terrault NA, Etzell JE, Damon LE. Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Reports. 2009; 3: 7335.

5. Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA. Hematologic Toxicity Associated with Interferon-Based Hepatitis C Therapy in HIV-1 Co-Infected Subjects. Clinical Infectious Diseases, 2007; 44(10): 1375-1383.

6. Behler CM, Shade SB, Gregory K, Abrams DI, Volberding

PA. Anemia and HIV in the Antiretroviral Era: Potential Significance of Testosterone. AIDS Research and Human Retroviruses 2005; 21(3): 200-6.

7. VM, Ketteler M, Frank RD, Schmitt H, Floege J, Behler

CM, Riehl J. Bone pain with scintigraphy suggestive of widespread metastases - do not forget phosphate. Brandenburg Nephrology Dialysis Transplantation 2002; 17(3): 504-7.

8. VanDevanter DR, Choongkittaworn NM, Dyer KA, Aten J, Otto P, Behler C, Bryant EM, Rabinovitch PS. Pure chromosome-specific PCR libraries from single sorted chromosomes. Proceedings of the National Academy of Sciences USA 1994; 91(13): 5858-5862.

  Review Articles and Chapters

Caroline Behler, Lawrence Kaplan. AIDS-Related

Lymphomas. Management of Hematologic Malignancies. Susan O’Brien, Hagop Kantarjian and Julie Vose, Ed. Cambridge University Press, New York, NY 2011.

2. Behler CM and Kaplan LD. Advances in the Management of HIV-Related Non-Hodgkin Lymphoma. Current Opinion in Oncology 2006 18(5): 437-443.

3. Caroline Behler, Patricia Cornett. Anemia in HIVInfection. Viral and Immunological Malignancies. Atlas of Clinical Oncology. Volberding PA and Palefsky JM, Ed. Black and Decker Inc., Hamilton, Ontario 2006.